Collaborative Advancement of Recovery Excellence
Translating science to service, powered by Gloo
A recently published study of 2017 data found that 60% of residential treatment centers in the U.S. offered zero medications for opioid use disorder and just 15% of patients had an MOUD as part of their treatment plan.
More than half of mental health practices surveyed by technology platform firm Kareo in June said that they have seen an increase in patient volume, fueled largely by the adoption of telehealth.
Citing data from the 2017 National Survey of Substance Abuse Treatment Services, an Office of the National Coordinator for Health Information Technology data brief notes that 29% of providers use only electronic records and 57% have a combination of electronic and paper records.
Deni Carise, PhD, chief science officer at Recovery Centers of America, joins the BHE Podcast to discuss the shift toward value-based and recovery-oriented care, and the importance of developing standard measures of both outcomes and performance during treatment. Carise also shares data on how…
Usage of telehealth services soared in April compared to the same month in 2019, primarily driven by patients seeking treatment for mental health conditions, according to data released by FAIR Health.
The Addiction Treatment Needs Assessment is a 13-question survey developed by Shatterproof, ASAM and the proprietors of OpenBeds to determine the needs of an individual with addiction and provide guidance on appropriate treatment.
A new site is launching in July with the aim of bringing more uniformity to the measurement of addiction treatment and helping patients find care with standardized information on the quality of facilities.
Five years after the concept was developed, Conquer Addiction, an online resource that will list providers who publish their post-treatment outcomes data, is set for a June 30 launch.
Gloo and the Psychiatry & Behavioral Health Learning Network have released a whitepaper on the impact of COVID-19 based on recent survey results.
A study of national commercial insurance claims conducted found that 16.6% of patients obtained follow-up treatment after a non-fatal opioid overdose, with patients who were older, female, black or Hispanic less likely to receive follow-up care.